New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 6, 2014
08:41 EDTBCLIBrainStorm Cell announces first patient enrollment in Phase II ALS trial
BrainStorm Cell announced that the first patient was enrolled in its Phase II ALS trial at Massachusetts General Hospital. BrainStorm's Phase II trial is a randomized, double-blind, placebo controlled multi-center study designed to evaluate the safety and efficacy of transplantation of Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors in 48 ALS patients. The trial is also being conducted at the University of Massachusetts Memorial Hospital and the Mayo Clinic in Rochester, Minnesota.
News For BCLI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 16, 2014
08:58 EDTBCLIBrainStorm CEO underappreciated by investors, Feuerstein says
BrainStorm CEO Tony Fiorino is "one of the most honest and diligent investors in the health care sector," TheStreet's Adam Feuerstein writes after interviewing the executive. Feuerstein believes Fiorino is being underappreciated by investors. Shares of the microcap company seeking to development a treatment for amyotrophic lateral sclerosis are up 20% to $4.15 in pre-open trading. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use